Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory phase IIa study of CL-197 capsules in treatment-naive adults with HIV-1 infection
CTR20254155Phase 2Active
- Sponsor
- Genuine Biotech
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CL-197 in Human immunodeficiency virus infection type 1, sponsored by Genuine Biotech. Started Nov 2025; status: active.
02
Drugs
CL-197
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on CTR20254155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254155.